Search clinical trials for: Nifedipine GITS (Adalat, BAYA1040), 30 mg

Total 31 results

Bayer

Completed

Study of Nifedipine GITS and Candesartan Combination Compared to Monotherapy in Patients With Essential Hypertension (DISTINCT)

Hypertension, Essential

Spain, Argentina, United States, Canada, Korea, Republic of, Italy, Russian Federation, South Africa, Ukraine, Belgium, Brazil, Lithuania, United Kingdom
Bayer

Completed

Nifedipine (Adalat CR, BAY A1040) High Dose PK/PD Study

Hypertension

Japan
Cao Yu

Unknown

Bioequivalence of Extended Release Nifedipine Tablets in Healthy Chinese Subjects

Therapeutic Equivalency

China
Bayer

Completed

Effectiveness and Tolerability of Long-Acting Nifedipine Gastrointestinal Therapeutic System in Chronic Kidney Disease With Uncontrolled Hypertension Patients, a Prospective, Multicenter, Observational Study (ADRENAL)

Hypertension

China
SocraTec R&D GmbH
SocraMetrics GmbH

Completed

Nifedipine Bioavailability Study With Oral Single Doses Under Fasting and Fed Conditions

Bioavailability, Therapeutical Indication Not Studied

Germany
Bayer

Completed

Blood Pressure Control of Nifedipine GITS 60mg Treatment in Chinese Hypertensive Subjects Uncontrolled on Starting-dose Mono-therapyo-therapy. (ADEPT)

Hypertension

China
Bayer

Completed

FOCUS (Nifedipine GITS's Effect on Central Pressure Assessed by Applanation Tonometry)

Hypertension

Korea, Republic of
National Taiwan University Hospital

Unknown

A Study of Nifecardia SRFC and Adalat OROS in the Treatment of Patients With Essential Hypertension

Hypertension

Taiwan
Bayer

Completed

Treatment of Hypertension With Adalat® in Combination With Other Drugs

Hypertension

Saudi Arabia, Jordan, Lebanon, Russian Federation, Bahrain, Egypt, United Arab Emirates, Morocco, Oman, Qatar, Pakistan
Shanghai Jiao Tong University School of Medicine

Completed

Amlodipine Prevents Morning Blood Pressure Surge Study (ARMORS)

Hypertension

China
Bayer

Completed

High Dose BAYA1040 CR: a Long Term Extension Study

Hypertension

Japan
Bayer

Completed

Single Dose Bioequivalence Study Comparing Nifedipine/Candesartan FDC (Fixed Dose Combination) With Loose Combination of Nifedipine GITS (Gastro-intestinal Therapeutic System) Plus Candesartan and Single Components Under Fasting Conditions

Hypertension, Essential

Germany
Bayer

Completed

Post-marketing Surveillance for Hypertensive Patients With Diabetes and/or Chronic Kidney Disease

Hypertension

Japan
Bayer

Completed

Effects of Adalat LA and Coracten on Drug Levels, Blood Pressure, and Heart Rate in Fed Patients With Hypertension

Hypertension

United Kingdom
Bayer

Completed

High Dose BAYA1040_Nifedipine: a Dose-comparative Study

Hypertension

Japan
Bayer

Completed

High Dose BAYA1040_Nifedipine: a Long Term Combination Study

Hypertension

Japan
Bayer

Completed

Controlled Release Nifedipine and Valsartan Combination Therapy in Patients With Essential Hypertension

Hypertension

Japan
The Baruch Padeh Medical Center, Poriya

Terminated

Extended Release Nifedipine Treatment as Maintenance Tocolysis to Prevent Preterm Delivery

Preterm Labor
Guangzhou First People's Hospital

Unknown

The Pharmacokinetics of Nifedipine Controlled Release Tablets in Hypertensive Patients on Hemodialysis (PICASSO)

Hypertension on Chronic Maintenance Hemodialysis

China
Jing Liu
Bayer

Terminated

Nifedipine GITS and Amlodipine Besylate on Recovery of Blood Pressure Rhythm and Arterial Stiffness (NARRAS)

Hypertension

China
Bayer

Completed

Low-dose Nifedipine-Valsartan Combination Compared to Up-titrated Valsartan Monotherapy in Essential Hypertension

Hypertension

China, Korea, Republic of
Bayer

Withdrawn

Monotherapy-Controlled Study of Nifedipine Gastrointestinal Therapeutic System and Candesartan Cilexetil in Combination in Subjects With Essential Hypertension Inadequately Controlled on Candesartan Cilexetil

Hypertension

Italy
Actavis Inc.

Completed

A Relative Bioavailability Study of 60 mg Nifedipine Extended Release Tablets Under Fasting Conditions

Healthy

United States
Actavis Inc.

Completed

A Relative Bioavailability Study of 60 mg Nifedipine ER Tablets Under Non-fasting Conditions

Healthy

United States
Ohio State University

Completed

Nifedipine XL Versus Placebo for the Treatment of Preeclampsia With Severe Features During Induction of Labor

Preeclampsia Severe

United States
Bayer

Completed

Single Dose Escalation Study to Investigate the Pharmacokinetics as Well as Safety and Tolerability of a Concomitant Administration of Nifedipne GITS and Candesartan Tablets Under Fasting Conditions in Healthy Male Subjects in an Open Label, Non-randomized, Sequential Design.

Clinical Pharmacology

Germany
Centura Health
Pulmodyne, Inc.

Completed

Evaluating the Utility of Continuous Positive Airway Pressure in the Treatment of High Altitude Pulmonary Edema

Continuous Positive Airway Pressure | High Altitude Pulmonary Edema

United States
University of Calgary

Recruiting

Treating Postictal Symptoms Using Ibuprofen and Nifedipine

Epilepsy | Epilepsies, Partial

Canada
Baskent University

Completed

Losartan Therapy in Pulmonary Hypertension

Pulmonary Hypertension
Acasti Pharma Inc.

Recruiting

Safety and Tolerability of GTX-104 Compared With Oral Nimodipine in Patients With aSAH (STRIVE-ON)

Aneurysmal Subarachnoid Hemorrhage (aSAH)

United States
Yang I. Pachankis

Completed

Medicine-induced Cardiac Hemodialysis on COVID-19

Renal Dialysis | Vaccines | Infection Viral | Severe Acute Respiratory Syndrome-related Coronavirus | Myocarditis Allergic

China

3

Subscribe